SFStefan Fischer

Stefan Fischer

*This is an algorithmically generated author record based on publicly available information.

Stefan Fischer has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Ali Akil

    Klinikum Ibbenbüren

    6 shared publications
  • Stephan Ziegeler

    Department of Anesthesiology, Intensive Care Medicine and Pain Management, Ibbenbueren General Hospital, Ibbenbueren Germany

    6 shared publications
  • Michael Semik

    Ibbenbueren Gen Hosp, Dept Thorac Surg & Lung Support, Ibbenburen, Germany

    4 shared publications
  • Bassam Redwan

    Sektion für Thoraxchirurgie, Universitätsklinik Münster, Deutschland

    3 shared publications
  • Mahyar Lavae-Mokhtari

    Department of Respiratory Medicine, Ibbenbueren General Hospital, Ibbenbueren, Germany

    3 shared publications
  • Stefan Freermann

    Department of Thoracic Surgery and Lung Support, Ibbenbueren General Hospital, Ibbenbueren, Germany

    3 shared publications

Latest Publications

  • Open Access

    Reply to Trudzinski et al. Comment on “Akil et al. Nonintubated versus Intubated Lung Volume Reduction Surgery in Patients with End-Stage Lung Emphysema and Hypercapnia. J. Clin. Med. 2023, 12, 3750”

    by Ali Akil, Stephanie Rehers, Stephan Ziegeler, Erik Ernst, Jan Haselmann, Nicolas Johannes Dickgreber, Stefan Fischer

    In response to the comment letter by Trudzinski et al.

  • Editorial

    by Stefan Fischer

    Verehrte Kolleginnen und Kollegen, im Rahmen der Jahrestagung der Deutschen Gesellschaft für Thoraxchirurgie 2024 in Magdeburg habe ich das Amt des Herausgebers des Zentralblatts für Chirurgie (ZBC) für die DGT von Herrn Prof. Bernward Passlick übernommen. Article published online: 05 February 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

  • Management tracheobronchialer Stenosen

    by Sandra C. Schulte, Stefan Fischer

    Tracheobronchiale Stenosen bestehen aus einem Spektrum von Erkrankungen, die in fokaler oder diffuser Enge der Trachea oder des nachgeschalteten Bronchialsystems resultieren können. In dieser Arbeit soll ein Überblick über die in der Praxis am häufigsten auftretenden Krankheitsbilder in Hinblick auf Diagnostik und therapeutische Optionen sowie die hiermit verbundenen Herausforderungen für die Praxis gegeben werden. Tracheobronchial stenoses consist of a spectrum of conditions that may result in focal or diffuse narrowing of the trachea or downstream bronchial system. The purpose of this paper is to provide an overview of the most commonly encountered conditions in terms of diagnosis and therapeutic options as well as the associated challenges for practitioners. Article published online: 02 June 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Open Access

    Nonintubated versus Intubated Lung Volume Reduction Surgery in Patients with End-Stage Lung Emphysema and Hypercapnia

    by Ali Akil, Stephanie Rehers, Stephan Ziegeler, Erik Ernst, Jan Haselmann, Nicolas Johannes Dickgreber, Stefan Fischer

    Lung volume reduction surgery (LVRS) represents an important treatment option in carefully selected patients with end-stage lung emphysema. The aim of this study was to assess the efficacy and safety of nonintubated LVRS compared to intubated LVRS in patients with preoperative hypercapnia and lung emphysema. Between April 2019 and February 2021, n = 92 patients with end-stage lung emphysema and preoperative hypercapnia undergoing unilateral video-assisted thoracoscopic LVRS (VATS-LVRS) performed in epidural anesthesia and mild sedation (nonintubated, group 1) or conventional general anesthesia (intubated, control, group 2) were prospectively enrolled in this study. Data were retrospectively analyzed. In all patients, low-flow veno-venous extracorporeal lung support (low-flow VV ECLS) was applied as a bridge through LVRS. Ninety-day mortality was considered as the primary outcome. Secondary endpoints included: chest tube duration, hospital stay, intubation and conversion to general anesthesia. Intergroup analysis showed no significant difference between the baseline data and patients’ demographics. N = 36 patients underwent nonintubated surgery. VATS-LVRS under general anesthesia was performed in n = 56 patients. The mean duration of postoperative VV ECLS support was 3 ± 1 day in group 1 compared to 4 ± 1 in group 2. The 90-day mortality rate was 3% in group 1 compared to 7% in group 2. In group 1, all chest tubes were removed 5 ± 1 day (range 4–32 days) and 8 ± 1 day (range 4–44 days) in the control group after the surgery (p < 0.02). Prolonged chest tube therapy (>8 days) was observed in n = 3 patients in group 1 and n = 11 patients in the control group. The mean ICU stay was 4 ± 1 days in group 1 compared to 8 ± 2 days in the control group (p = 0.04). The mean hospital stay was significantly shorter in the nonintubated group 1 (6 ± 2 days vs. 10 ± 4 days, p = 0.01). Conversion to general anesthesia was necessary in one patient due to severe pleural adhesions. Nonintubated VATS-LVRS in patients with end-stage lung emphysema and hypercapnia is effective and well tolerated. Compared to general anesthesia, a reduction in mortality, chest tube duration, ICU and hospital stay and lower rate of prolonged air leak was observed. VV ECLS increases intraoperative safety and mitigates postoperative complications in such “high-risk” patients.


  • Empfehlungen der S3-Leitlinie (AWMF) „Einsatz der extrakorporalen Zirkulation (ECLS/ECMO) bei Herz- und Kreislaufversagen“

    by Stefan Fischer, Alexander Assmann, Andreas Beckmann, Christof Schmid, Karl Werdan, Guido Michels, Oliver Miera, Florian Schmidt, Stefan Klotz, Christoph Starck, et al.

    Zusammenfassung: In den vergangenen Jahren hat der Einsatz mechanischer Unterstützungssysteme für Patienten mit Herz- und Kreislaufversagen kontinuierlich zugenommen, sodass in Deutschland mittlerweile jährlich etwa 3000 ECLS-/ECMO-Systeme implantiert werden. Vor dem Hintergrund bislang fehlender umfassender Leitlinien bestand ein dringlicher Bedarf an der Formulierung evidenzbasierter Empfehlungen zu den zentralen Aspekten der ECLS-/ECMO-Therapie. Im Juli 2015 wurde daher die Erstellung einer S3-Leitlinie durch die Deutsche Gesellschaft für Thorax-, Herz- und Gefäßchirurgie (DGTHG) bei der zuständigen Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF) angemeldet. In einem strukturierten Konsensusprozess mit Einbindung von Experten aus Deutschland, Österreich und der Schweiz, delegiert aus 11 AWMF-Fachgesellschaften, 5 weiteren Fachgesellschaften sowie der Patientenvertretung, entstand unter Federführung der DGTHG die Leitlinie „Einsatz der extrakorporalen Zirkulation (ECLS/ECMO) bei Herz- und Kreislaufversagen“, die im Februar 2021 publiziert wurde. Die Leitlinie fokussiert auf klinische Aspekte der Initiierung, Fortführung, Entwöhnung und Nachsorge und adressiert hierbei auch strukturelle und ökonomische Fragestellungen. Dieser Artikel präsentiert eine Übersicht zu der Methodik und den konsentierten Empfehlungen.

  • Lung Volume Reduction Surgery Reduces Pulmonary Arterial Hypertension Associated With Severe Lung Emphysema and Hypercapnia

    by Ali Akil, Stephan Ziegeler, Stephanie Rehers, Mahyar Lavae-Mokhtari, Lars Richter, Nicolas Johannes Dickgreber, Erik Christian Ernst, Stefan Fischer

    Lung volume reduction surgery (LVRS) represents a standard surgical approach for patients with severe pulmonary emphysema. One of the relevant risk factors for LVRS is the presence of pulmonary arterial hypertension (PAH). The aim of this study is to assess the postoperative changes in pulmonary arterial pressure (PAP) after LVRS for patients with severe pulmonary emphysema compared with preoperative measures. N = 61 consecutive patients with severe pulmonary emphysema and preoperative evidence for PAH (pulmonary arterial systolic pressure [PASP] ≥ 35 mmHg) were prospectively included into this study. In all patients, thoracoscopic LVRS was performed. PASP was assessed by echocardiography before surgery, early postoperatively, and 3 months after surgery. Data were prospectively recorded and analyzed retrospectively. Primary end points were the postoperative changes in PASP as well as the 90 day mortality rate. Secondary endpoints included: pulmonary function test, exercise capacity, quality of life, and dyspnea symptoms (Borg scale). Early after surgery, a significant reduction in PASP was observed at the day of discharge and at 3 month follow-up. In n = 34 patients, no tricuspid valve regurgitation was detectable anymore suggesting normal PAP. In n = 3 patients, venovenous extracorporeal lung support (VV ECLS) was already implemented preoperatively. In the remaining cases, VV ECLS was applied intraoperatively and continued postoperatively. Mean duration of postoperative ECLS support was 2 days. Four patients died due to acute right heart failure, two patients from sepsis with multiorgan failure, and one patient from acute pulmonary embolism. Ninety day mortality was 11.5 %. A significant improvement was postoperatively observed regarding the performance status, dyspnea scale, as well as quality of life. This study suggests a beneficial effect of LVRS on PAP, which may ultimately help to protect and stabilize right ventricular function. Further studies, implementing pre- and postoperative right heart catheterizations including invasive PAP evaluation, are necessary to support the findings in this study in greater detail.


  • Open Access

    Multidisciplinary management of pleural infection after ventricular assist device implantation

    by Ali Akil, Stephanie Rehers, Christian Köhler, Lars Richter, Michael Semik, Stephan Ziegeler, Stefan Fischer

    Multidisciplinary management of pleural infection after ventricular assist device implantation Ali Akil, Stephanie Rehers, Christian Köhler, Lars Richter, Michael Semik, Stephan Ziegeler, Stefan Fischer


  • ECMO in der Thoraxchirurgie: Grundlagen und Pathophysiologie

    by B. Redwan, C. Freermann, A. Akil, S. Fischer

    Die extrakorporale Lungenunterstützung (ECLS) stellt heutzutage ein gut etabliertes Verfahren in der Thoraxchirurgie dar. In Abhängigkeit von der respiratorischen und hämodynamischen Situation des Patienten wird die ECLS in verschiedenen Modalitäten eingesetzt. Dies erfordert ein ausreichendes Wissen über die verschiedene ECMO-Modalitäten (ECMO: extrakorporale Membranoxygenierung), Kanülierungswege, zur Verfügung stehendes technisches Equipment und über die pathophysiologischen Grundlagen im Zusammenhang mit derartiger Technologie, um das individuell auf die Patientenbedürfnisse angepasste Verfahren zu wählen. Dementsprechend kann die Therapie je nach klinischer Situation im Verlauf eskaliert bzw. deeskaliert werden. Extracorporeal lung support (ECLS) is of increasing importance in general thoracic surgery. Different modes of ECLS may be applied in several situations throughout the perioperative phase and are adapted to the individual patientʼs needs and the planned surgical procedures. ECLS is not a static procedure and should be always evaluated according to the present condition of the patient. Therefore, it is essential to understand the pathophysiology of the disease and the different ECLS modes, as well as the different cannulation options, in order to be able to use the different escalation and de-escalation techniques in accordance with the clinical situation. Publication Date: 18 January 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Veno-Venous Extracorporeal Lung Support as a Bridge to or Through Lung Volume Reduction Surgery in Patients with Severe Hypercapnia

    by Ali Akil, Stephan Ziegeler, Jan Reichelt, Mahyar Lavae-Mokhtari, Stefan Freermann, Michael Semik, Joachim Fichter, Stephanie Rehers, Nicolas Johannes Dickgreber, Lars Richter, et al.

    Extracorporeal lung support (ECLS) represents an essential support tool especially for critically ill patients undergoing thoracic surgical procedures. Lung volume reduction surgery (LVRS) is an important treatment option for end-stage lung emphysema in carefully selected patients. Here, we report the efficacy of veno-venous ECLS (VV ECLS) as a bridge to or through LVRS in patients with end-stage lung emphysema and severe hypercapnia. Between January 2016 and May 2017, 125 patients with end-stage lung emphysema undergoing LVRS were prospectively enrolled into this study. Patients with severe hypercapnia caused by chronic respiratory failure were bridged to or through LVRS with low-flow VV ECLS (65 patients, group 1). Patients with preoperative normocapnia served as a control group (60 patients, group 2). In group 1, VV ECLS was implemented preoperatively in five patients and in 60 patients intraoperatively. Extracorporeal lung support was continued postoperatively in all 65 patients. Mean length of postoperative VV ECLS support was 3 ± 1 day. The 90 day mortality rate was 7.8% in group 1 compared with 5% in group 2 (p = 0.5). Postoperatively, a significant improvement was observed in quality of life, exercise capacity, and dyspnea symptoms in both groups. VV ECLS in patients with severe hypercapnia undergoing LVRS is an effective and well-tolerated treatment option. In particular, it increases the intraoperative safety, supports de-escalation of ventilatory strategies, and reduces the rate of postoperative complications in a cohort of patients considered “high risk” for LVRS in the current literature.


  • Rib osteosynthesis is a safe and effective treatment and leads to a significant reduction of trauma associated pain

    by Ali Akil, Stephan Ziegeler, Jan Reichelt, Michael Semik, Marcus Christian Müller, Stefan Fischer

    The usefulness of chest wall stabilization after blunt chest wall trauma with unstable rib fractures has recently been intensely discussed. Thereby, the surgical approach seems to influence outcome, mortality and the long-term complication rate including chronic chest pain, thoracic deformity and quality of life. Here, we present the outcome after surgical stabilization of unstable rib fractures using intramedullary splints and plate osteosynthesis.